Saama has unveiled groundbreaking features in its AI-driven platform, ushering in a new era of collaboration in clinical development. The introduction of Generative AI (GenAI) chat and Interactive Review Listings (IRL) empowers users to interact with their data using natural language, receiving instant responses and eliminating the delays associated with traditional data analysis methods. This transformative shift allows data management and medical review teams to collaborate seamlessly within a unified system, streamlining comprehensive data reviews and breaking down operational silos in the clinical development process.
The platform's innovations extend further with features like Data Quality (DQ) Co-Pilot, which leverages GenAI to automate the generation of accurate code and test data for data quality checks. Additionally, Chat for Patient Insights enables medical monitors to query data in natural language, creating custom listings without the need for programmers. Saama's Data Hub now offers enhanced capabilities, allowing users to apply different data standards by study, manage blinded datasets, and leverage AI-driven data mapping for faster standardisation of clinical trial data.
By deploying these advanced tools, clinical trial sponsors and research organisations can significantly reduce the time from data capture to query generation, achieving nearly a one-month reduction in the process. Saama's commitment to innovation and the continued evolution of its platform reflects a dedication to modernising research and development, enabling clinical development teams to derive valuable insights from data and drive medical breakthroughs efficiently.
Click here to read the original news story.